Navigation Links
NIH funds researchers using light to control and monitor neural activity
Date:11/7/2013

University of Texas at Arlington researchers are exploring a better method for initiating certain gene therapies that could better fight the sight-deteriorating disease retinitis pigmentosa.

The National Institutes of Health is funding the research.

Samarendra Mohanty, assistant professor of physics, expects to receive a total of $384,269 over the next two years from the NIH's National Institute of Neurological Disorders and Stroke. His work involves using a near-infrared ultrafast laser beam to deliver genes that allow expression of light-sensitive proteins, called opsins, in specific cells. That proteins' expression allows researchers to influence neural activity through optical or light stimulation a technique known as optogenetics. In the past, the genes have been delivered to cells by virus. That method can have drawbacks, such as immune responses, in addition to the benefits. In Mohanty's method, a laser beam creates a transient sub-micrometer size hole, which allows for the gene encoding the proteins to permeate through the cell membrane. It can limit the risk of immune response, as well as delivering larger genes than viral methods, he said.

Digant Dave, UT Arlington associate professor of bioengineering at UT Arlington, is the co-investigator on the new grant. "Our minimally invasive near-infrared method can deliver DNA and other impermeable molecules effectively where you want it and only where you want it," said Mohanty. "For example, in retinitis pigmentosa, only peripheral retina begins to lose light sensitivity due to loss of photoreceptors. This is where a laser can deliver the genes, making those neurons respond to light again. With a virus, the genes will be delivered everywhere, causing complications in areas already working fine."

Optogenetic stimulation also holds promise for influencing neurons in the brain. Scientists, including Mohanty's research group, are researching ways it could be used to understand how the brain works or to intervene in case of neurological disorders or to affect behavior.

Ultimately, Mohanty's team has a goal of creating all optical, or light-based, control and monitoring of cell activity. So, in addition to the light-assisted delivery of genes, the researchers also will work on refining methods for stimulating the neural activity using near-infrared and visible light. Some of those methods are described in a recently published paper called "Fiber-optic two-photon optogenetic stimulation," which appeared in the journal Optics Letters.

Mohanty's lab at UT Arlington also will use a method called phase-sensitive interferometry, to monitor the changes in neurons that result from the activation by light. The interferometry method is called "label-free" because unlike fluorescence, it uses the change in behavior of light rays, rather than staining, to track changes at the sub-nanometer level.

"Dr. Mohanty's proven track record of exploration in the area of optogenetics has earned him this support from the National Institutes of Health," said Alex Weiss, chairman of the College of Science's physics department. "We are pleased to see this promising research supported and look forward to seeing the exciting research findings that this support will make possible."


'/>"/>

Contact: Traci Peterson
tpeterso@uta.edu
817-521-5494
University of Texas at Arlington
Source:Eurekalert  

Related biology news :

1. Researchers at GW receive federal funds to study the effect earthquakes have on nuclear reactors
2. NIH funds development of tissue chips to help predict drug safety
3. WaterSMART funds $1.7 million for science projects in desert and southern Rockies LCCs
4. EU FET program funds research on 3D neuronal structures mimicking human brain tissue
5. CIRM funds 6 UC San Diego stem cell researchers
6. NASA funds SAO instrument to track North American air pollution
7. Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries
8. Energy Deptartment funds UW project to turn wasted natural gas into diesel
9. NIH grant funds Boston College research into illnesses afflicting people living with HIV
10. NIH funds research to identify Parkinsons biomarkers
11. March of Dimes funds new preterm birth research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIH funds researchers using light to control and monitor neural activity
(Date:2/13/2017)... Feb. 13, 2017 Former 9/11 Commission border ... Committee, Janice Kephart of Identity Strategy Partners, ... Donald Trump,s "Executive Order: Protecting the Nation From ... 2017):  "As President Trump,s ,Travel Ban, Executive ... now essentially banned the travel ban, it is important ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global ... reach $11.4 billion by 2021, growing at a compound annual ... - An overview of the global markets for synthetic biology. ... estimates for 2016, and projections of compound annual growth rates ...
(Date:2/7/2017)... , February 7, 2017 Ipsidy ... Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a ... transaction processing services, is pleased to announce the following ... Effective January 31, 2017, Philip D. ... Directors, CEO and President.  An experienced payment industry professional ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... FRANCISCO , Feb. 24, 2017 Symic ... is developing a new category of therapeutics, announced today ... of SB-030 in peripheral artery disease. The trial will ... administered single-use therapeutic, in the reduction of restenosis following ... this critical development milestone for SB-030," said Nathan ...
(Date:2/24/2017)... ... February 24, 2017 , ... FireflySci, Inc is an explosive small ... FireflySci had the goal of bringing their powerful cuvette and spectrophotometer calibration ... path that FireflySci is going on as they add yet another mark on the ...
(Date:2/24/2017)... 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a ... Key Opinion Leader event to highlight new clinical data ... presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and ... be held in-person and via live webcast on Tuesday, ... PST at the Lotte New York Palace Hotel in ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook Labs is formalizing ... an array of biochemical analyses critical for Lead Discovery. The company’s Lead ... SAR programs, including inhibitor potency and selectivity, mechanism of action, and inhibitor residence ...
Breaking Biology Technology: